A multicenter trial on the efficacy of using tirilazad mesylate in cases of head injury

Journal of Neurosurgery

Volumn 89, Issue 4, 1998, Pages 519-525

  Marshall, Lawrence F ^a   Maas, Andrew I R ^b   Marshall, Sharon Bowers ^b   Bricolo, Albino ^b   Fearnside, Michael ^b   Iannotti, Fausto ^b   Klauber, Melville R ^b   Lagarrigue, Jacques ^b   Lobato, Ramiro ^b   Persson, Lennart ^b   Pickard, John D ^b   Piek, Jürgen ^b   Servadei, Franco ^b   Wellis, Georgios N ^b   Morris, Gabrielle F ^b   Means, Eugene D ^b   Musch, Bruno ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

21 aminosteroid; Moderate head injury; Neurotrauma; Severe head injury; Tirilazad mesylate

Indexed keywords

TIRILAZAD;

ADULT; ARTICLE; BRAIN EDEMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG INDICATION; FEMALE; HEAD INJURY; HEART ARREST; HUMAN; HYPOTENSION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PRIORITY JOURNAL; SEPSIS; SKIN IRRITATION; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME;

EID: 0031657984     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.1998.89.4.0519     Document Type: Article

References (13)

1. Chesnut RM, Marshall LF, Klauber MR, et al.: The role of secondary brain injury in determining outcome from severe brain injury. J Trauma 34:216-222, 1993
2. Hall ED, Braughler JM: Central nervous system trauma and stroke: II. Physiological and pharmacological evidence for the involvement of oxygen radicals and liquid peroxidation. Free Rad Biol Med 6:303-313, 1989
3. Hall ED, Braughler JM: Free radicals in CNS injury, in Waxman SG (ed): Molecular and Cellular Approaches to the Treatment of Neurological Disease. New York: Raven Press, 1993, pp 79-91
4. Hall ED, Yonkers PA, Andrus PK, et al: Biochemistry and pharmacology of lipid antioxidants in acute brain and spinal cord injury. J Neurotrauma 9 (Suppl 2):425-442, 1992
5. Hall ED, Yonkers PA, McCall JM, et al: Effects of the 21-aminosteroid U-74006F on experimental head injury in mice. J Neurosurg 68:456-461, 1988
6. Jennett B, Bond M: Assessment of outcome after severe brain damage. A practical scale. Lancet 1:480-484, 1975
7. Kassell NF, Haley EC, Apperson-Hansen C, et al: A randomized double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in Europe/Australia/New Zealand. J Neurosurg 84:221-228, 1996
8. Marshall LF, Marshall SB, Klauber MR, et al: A new classification of head injury based on computerized tomography. J Neurosurg 75 (Suppl):S14-S20, 1991
9. McIntosh TK, Thomas M, Smith D: The novel 21-ammosteroid U-74006F attenuates cerebral edema and improves survival after brain injury in the rat. J Neurotrauma 9:33-46, 1992
10. McIntosh TK, Vink R, Soares H, et al: Effects of the N-methyl-D-aspartate receptor blocker MK-801 on neurologic function after experimental brain injury. J Neurotrauma 6:247-259, 1989
11. Murray GD, Teasdale GM, Schmitz H: Nimodipine in traumatic subarachnoid hemorrhage: a re-analysis of the HIT I and HIT II trials. Acta Neurochir 138:1163-1167, 1996
12. Ott L, McClain CJ, Gilespe M, et al: Cytokines in metabolic dysfunction after severe head injury. J Neurotrauma 11: 447-472, 1994
13. Young B, Runge JW, Waxman KS, et al: Effect of pegorgotein on neurological outcome of patients with severe head injury: a multicenter, randomized, controlled trial. JAMA 276:538-543, 1996